{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:18:49Z","timestamp":1791418729919,"version":"4.3.3"},"reference-count":71,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2004,9,1]],"date-time":"2004-09-01T00:00:00Z","timestamp":1093996800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,8,22]],"date-time":"2013-08-22T00:00:00Z","timestamp":1377129600000},"content-version":"vor","delay-in-days":3277,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the American College of Cardiology"],"published-print":{"date-parts":[[2004,9]]},"DOI":"10.1016\/j.jacc.2004.05.070","type":"journal-article","created":{"date-parts":[[2004,8,31]],"date-time":"2004-08-31T16:58:01Z","timestamp":1093971481000},"page":"959-966","source":"Crossref","is-referenced-by-count":206,"title":["Anemia as a risk factor and therapeutic target in heart failure"],"prefix":"10.1016","volume":"44","author":[{"given":"G. Michael","family":"Felker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"Kirkwood F.","family":"Adams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy A.","family":"Gattis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher M.","family":"O'Connor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2004.05.070_bib1","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1016\/S0735-1097(03)00245-6","article-title":"Heart failure therapy at a crossroad: are there limits to the neurohormonal model?","volume":"41","author":"Mehra","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2004.05.070_bib2","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1016\/S0735-1097(01)01683-7","volume":"38","author":"Hunt","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2004.05.070_bib3","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1053\/euhj.2001.2783","article-title":"Guidelines for the diagnosis and treatment of chronic heart failure","volume":"22","author":"Remme","year":"2001","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2004.05.070_bib4","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0735-1097(01)01470-X","article-title":"Reduced kidney function and anemia as risk factors for mortality in patients with left ventricular dysfunction","volume":"38","author":"Al-Ahmad","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2004.05.070_bib5","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1016\/S0735-1097(03)00425-X","article-title":"Anemia predicts mortality in severe heart failure: the Prospective Randomized Amlodipine Survival Evaluation (PRAISE)","volume":"41","author":"Mozaffarian","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2004.05.070_bib6","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1016\/S0735-1097(00)00613-6","article-title":"The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospitalizations","volume":"35","author":"Silverberg","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2004.05.070_bib7","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0167-5273(02)00273-5","article-title":"The prevalence of anemia in chronic heart failure","volume":"86","author":"Tanner","year":"2002","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacc.2004.05.070_bib8","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1161\/01.CIR.0000052622.51963.FC","article-title":"Anemia is common in heart failure and is associated with poor outcomes: insights from a cohort of 12,065 patients with new-onset heart failure","volume":"107","author":"Ezekowitz","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2004.05.070_bib9","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1016\/S0735-1097(02)01854-5","article-title":"Anemia is associated with worse symptoms, greater impairment in functional capacity and a significant increase in mortality in patients with advanced heart failure","volume":"39","author":"Horwich","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2004.05.070_bib10","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S0002-9343(02)01498-5","article-title":"The prognostic importance of anemia in patients with heart failure","volume":"114","author":"Kosborod","year":"2003","journal-title":"Am J Med"},{"key":"10.1016\/j.jacc.2004.05.070_bib11","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1159\/000213315","article-title":"Prevalence and causes of anaemia in a geriatric hospitalized population","volume":"38","author":"Joosten","year":"1992","journal-title":"Gerontology"},{"key":"10.1016\/j.jacc.2004.05.070_bib12","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S0735-1097(99)00608-7","article-title":"The prognostic implications of renal insufficiency in asymptomatic and symptomatic patients with left ventricular systolic dysfunction","volume":"35","author":"Dries","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2004.05.070_bib13","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1161\/01.CIR.102.2.203","article-title":"Renal function, neurohormonal activation, and survival in patients with chronic heart failure","volume":"102","author":"Hillege","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2004.05.070_bib14","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S1071-9164(03)00338-5","article-title":"Chronic heart failure is not an independent cause of anemia","volume":"9","author":"Hussein","year":"2003","journal-title":"J Card Failure"},{"key":"10.1016\/j.jacc.2004.05.070_bib15","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S1071-9164(03)00252-5","article-title":"STAMINA-HFP (Study of Anemia in a Heart Failure Population) registry: rationale, design, and patient characteristics","volume":"9","author":"Adams","year":"2003","journal-title":"J Card Failure"},{"issue":"Suppl 2","key":"10.1016\/j.jacc.2004.05.070_bib16","first-page":"7","article-title":"Outcomes of anaemia management in renal insufficiency and cardiac disease","volume":"18","author":"Silverberg","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jacc.2004.05.070_bib17","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/0002-9149(94)90905-9","article-title":"Blood levels of erythropoietin in congestive heart failure and correlation with clinical, hemodynamic, and hormonal profiles","volume":"74","author":"Volpe","year":"1994","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2004.05.070_bib18","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1161\/01.CIR.0000052623.16194.80","article-title":"Hemodilution is common in patients with advanced heart failure","volume":"107","author":"Androne","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2004.05.070_bib19","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/S0735-1097(02)02125-3","volume":"40","author":"Mahon","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2004.05.070_bib20","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0272-6386(96)90130-4","article-title":"The impact of anemia on cardiomyopathy, morbidity, and mortality in end-stage renal disease","volume":"28","author":"Foley","year":"1996","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jacc.2004.05.070_bib21","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/0272-6386(95)90673-8","article-title":"Cardiac function and hematocrit level","volume":"25","author":"Harnett","year":"1995","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jacc.2004.05.070_bib22","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1056\/NEJM199007263230405","article-title":"Elevated circulating levels of tumor necrosis factor in severe chronic heart failure","volume":"323","author":"Levine","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2004.05.070_bib23","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1161\/01.CIR.103.16.2055","article-title":"Cytokines and cytokine receptors in advanced heart failure: an analysis of the cytokine database from the Vesnarinone Trial (VEST)","volume":"103","author":"Deswal","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2004.05.070_bib24","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/0735-1097(95)00589-7","article-title":"Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the Studies Of Left Ventricular Dysfunction (SOLVD)","volume":"27","author":"Torre-Amione","year":"1996","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2004.05.070_bib25","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1006\/clim.1999.4736","article-title":"Role of cytokines in the pathogenesis of anemia of chronic disease in rheumatoid arthritis","volume":"92","author":"Voulgari","year":"1999","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jacc.2004.05.070_bib26","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S1071-9164(03)00458-5","article-title":"Anemia and inflammation in chronic heart failure","volume":"9","author":"Bolger","year":"2003","journal-title":"J Card Failure"},{"key":"10.1016\/j.jacc.2004.05.070_bib27","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/0735-1097(94)00417-O","article-title":"Effect of long-term digoxin therapy on autonomic function in patients with chronic heart failure","volume":"25","author":"Krum","year":"1995","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2004.05.070_bib28","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0165-1838(00)00099-0","article-title":"Mechanism of anemia associated with autonomic dysfunction in rats","volume":"82","author":"Obayashi","year":"2000","journal-title":"Auton Neurosci"},{"key":"10.1016\/j.jacc.2004.05.070_bib29","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1056\/NEJM199108013250502","article-title":"A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure","volume":"325","author":"Cohn","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2004.05.070_bib30","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1056\/NEJM198706043162301","article-title":"Effects of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS)","volume":"316","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2004.05.070_bib31","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1056\/NEJM199108013250501","article-title":"Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure","volume":"325","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2004.05.070_bib32","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1016\/S0140-6736(82)92430-8","article-title":"Enalapril (MK-420) and the white cell count and haematocrit","volume":"319","author":"Griffing","year":"1982","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2004.05.070_bib33","doi-asserted-by":"crossref","first-page":"611","DOI":"10.3109\/00365519009089178","article-title":"Effect of enalapril on haemoglobin and serum erythropoietin in patients with chronic nephropathy","volume":"50","author":"Kamper","year":"1990","journal-title":"Scan J Clin Lab Invest"},{"key":"10.1016\/j.jacc.2004.05.070_bib34","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S0140-6736(02)07812-1","article-title":"Angiotensin-converting-enzyme inhibition therapy in altitude polycythaemia: a prospective randomised trial","volume":"359","author":"Plata","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2004.05.070_bib35","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1365-2796.1989.tb01390.x","article-title":"High serum erythropoietin levels are normalized during treatment of congestive heart failure with enalapril","volume":"226","author":"Fyhrquist","year":"1989","journal-title":"J Intern Med"},{"key":"10.1016\/j.jacc.2004.05.070_bib36","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0735-1097(02)01938-1","article-title":"Anemia as a risk factor for cardiovascular disease in the Atherosclerosis Risk In Communities (ARIC) study","volume":"40","author":"Sarnak","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2004.05.070_bib37","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1093\/eurheartj\/8.suppl_F.23","article-title":"Epidemiology and prevention of cardiac failure: Framingham study insights","volume":"8","author":"Kannel","year":"1998","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2004.05.070_bib38","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/S0002-9149(03)00740-9","article-title":"Usefulness of anemia as a predictor of death and rehospitalization in patients with decompensated heart failure","volume":"92","author":"Felker","year":"2003","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2004.05.070_bib39","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/S0002-9149(03)00030-4","article-title":"Effect of anemia on exercise tolerance in chronic heart failure in men","volume":"91","author":"Kalra","year":"2003","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2004.05.070_bib40","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0140-6736(03)13912-8","article-title":"Haemoglobin concentration and prognosis in new cases of heart failure","volume":"362","author":"Kalra","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2004.05.070_bib41","first-page":"IV665","article-title":"Anemia is not and independent predictor of mortality in patients with heart failure\u2014results from the National Heart Failure Project","volume":"108","author":"Kosiborod","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2004.05.070_bib42","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1001\/jama.279.3.217","article-title":"Human cardiovascular and metabolic response to acute, severe isovolumic anemia","volume":"279","author":"Weiskopf","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2004.05.070_bib43","first-page":"H340","article-title":"Limit to cardiac compensation during acute isovolumic hemodilution: influence of coronary stenosis","volume":"265","author":"Levy","year":"1993","journal-title":"Am J Physiol"},{"key":"10.1016\/j.jacc.2004.05.070_bib44","doi-asserted-by":"crossref","first-page":"393","DOI":"10.7326\/0003-4819-116-5-393","article-title":"Prudent strategies for elective red blood cell transfusion","volume":"116","author":"Welch","year":"1992","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacc.2004.05.070_bib45","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1056\/NEJM199902113400606","article-title":"Transfusion medicine: first of two parts\u2014blood transfusion","volume":"340","author":"Goodnough","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2004.05.070_bib46","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1056\/NEJM199902113400601","article-title":"A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care: transfusion requirements in critical care investigators, Canadian Critical Care Trials Group","volume":"340","author":"Hebert","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2004.05.070_bib47","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1056\/NEJMoa010615","article-title":"Blood transfusion in elderly patients with acute myocardial infarction","volume":"345","author":"Wu","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2004.05.070_bib48","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1159\/000168273","article-title":"Therapy with recombinant human erythropoietin reduces cardiac size and improves heart function in chronic hemodialysis patients","volume":"11","author":"Low-Friedrich","year":"1991","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.jacc.2004.05.070_bib49","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/0002-8703(92)90608-X","article-title":"Changes in left ventricular size, wall thickness, and function in anemic patients treated with recombinant human erythropoietin","volume":"124","author":"Goldberg","year":"1992","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2004.05.070_bib50","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3109\/00365599609180900","article-title":"Renal anemia treatment with recombinant human erythropoietin increases cardiac output in patients with ischemic heart disease","volume":"30","author":"Linde","year":"1996","journal-title":"Scand J Urol Nephrol"},{"key":"10.1016\/j.jacc.2004.05.070_bib51","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1016\/S0735-1097(01)01248-7","article-title":"The effect of correction of mild anemia in severe, resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron: a randomized controlled study","volume":"37","author":"Silverberg","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2004.05.070_bib52","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1161\/01.CIR.0000044914.42696.6A","article-title":"Effect of erythropoietin on exercise capacity in patients with moderate to severe chronic heart failure","volume":"107","author":"Mancini","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2004.05.070_bib53","first-page":"1","article-title":"Erythropoietic, neurotrophic, and angiogenic functions of erythropoietin and regulation of erythropoietin production","volume":"70","author":"Masuda","year":"1999","journal-title":"Int J Hematol"},{"key":"10.1016\/j.jacc.2004.05.070_bib54","doi-asserted-by":"crossref","first-page":"4802","DOI":"10.1073\/pnas.0630444100","article-title":"Recombinant human erythropoietin protects the myocardium from ischemia-reperfusion injury and promotes beneficial remodeling","volume":"100","author":"Calvillo","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jacc.2004.05.070_bib55","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1172\/JCI18200","article-title":"A novel protective effect of erythropoietin in the infarcted heart","volume":"112","author":"Parsa","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jacc.2004.05.070_bib56","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1056\/NEJM199808273390903","article-title":"The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin","volume":"339","author":"Besarab","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2004.05.070_bib57","doi-asserted-by":"crossref","first-page":"3030","DOI":"10.1093\/ndt\/13.12.3030","article-title":"The Normal Haematocrit trial in dialysis patients with cardiac disease: are we any less confused about target hemoglobin?","volume":"13","author":"Macdougall","year":"1998","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jacc.2004.05.070_bib58","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1046\/j.1523-1755.2000.00289.x","article-title":"Effect of hemoglobin levels in hemodialysis patients with asymptomatic cardiomyopathy","volume":"58","author":"Foley","year":"2000","journal-title":"Kidney Int"},{"key":"10.1016\/j.jacc.2004.05.070_bib59","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1681\/ASN.V112335","article-title":"Increasing the hematocrit has a beneficial effect on quality of life and is safe in selected hemodialysis patients","volume":"11","author":"Moreno","year":"2000","journal-title":"J Am Soc Nephrol"},{"issue":"Suppl 2","key":"10.1016\/j.jacc.2004.05.070_bib60","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1093\/ndt\/10.supp2.80","article-title":"Hypertension and cardiovascular effects\u2014long-term safety and potential long-term benefits of r-HuEPO","volume":"10","author":"Mann","year":"1995","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jacc.2004.05.070_bib61","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1055\/s-0038-1656096","article-title":"Erythropoietin potentiates thrombus development in a canine arterio-venous shunt model","volume":"77","author":"Wolf","year":"1997","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jacc.2004.05.070_bib62","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1681\/ASN.V4101809","article-title":"Probability of thrombosis of vascular access among hemodialysis patients treated with recombinant human erythropoietin","volume":"4","author":"Churchill","year":"1994","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.jacc.2004.05.070_bib63","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/oxfordjournals.ndt.a092112","article-title":"Prothrombotic effect of erythropoietin in dialysis patients","volume":"7","author":"Taylor","year":"1992","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jacc.2004.05.070_bib64","first-page":"811","article-title":"Erythropoietin for anaemia in haemodialysis patients: results of a maintenance study (the Canadian Erythropoietin Study Group)","volume":"7","author":"Muirhead","year":"1992","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jacc.2004.05.070_bib65","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1159\/000013349","article-title":"Effects of epoetin alfa on hemostasis in chronic renal failure","volume":"18","author":"Tang","year":"1998","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.jacc.2004.05.070_bib66","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/oxfordjournals.ndt.a092112","article-title":"Prothrombotic effect of erythropoietin in dialysis patients","volume":"7","author":"Taylor","year":"1992","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jacc.2004.05.070_bib67","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1093\/ndt\/6.11.862","article-title":"Coagulation studies and fistula blood flow during erythropoietin therapy in haemodialysis patients","volume":"6","author":"Macdougall","year":"1991","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jacc.2004.05.070_bib68","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1038\/ki.1993.142","article-title":"Recombinant human erythropoietin (rHuEPO) increases endothelin-1 release by endothelial cells","volume":"43","author":"Carlini","year":"1993","journal-title":"Kidney Int"},{"key":"10.1016\/j.jacc.2004.05.070_bib69","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/0735-1097(95)00520-X","article-title":"Prognostic impact of big endothelin-1 plasma concentrations compared with invasive hemodynamic evaluation in severe heart failure","volume":"27","author":"Pacher","year":"1996","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2004.05.070_bib70","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1067\/mhj.2001.117606","article-title":"Inotropic therapy for heart failure: an evidence-based approach","volume":"142","author":"Felker","year":"2001","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2004.05.070_bib71","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S1388-9842(01)00149-0","article-title":"Clinical trials update: CAPRICORN, COPERNICUS, MIRACLE, STAF, RITZ-2, RECOVER and RENAISSANCE and cachexia and cholesterol in heart failure: highlights of the Scientific Sessions of the American College of Cardiology, 2001","volume":"3","author":"Louis","year":"2001","journal-title":"Eur J Heart Fail"}],"container-title":["Journal of the American College of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109704012197?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109704012197?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,6,25]],"date-time":"2021-06-25T10:08:21Z","timestamp":1624615701000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109704012197"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,9]]},"references-count":71,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2004,9]]}},"alternative-id":["S0735109704012197"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2004.05.070","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2004,9]]}}}